BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goldrat O, Delbaere A. PCOS: update and diagnostic approach. Clin Biochem 2018;62:24-31. [PMID: 30195483 DOI: 10.1016/j.clinbiochem.2018.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Haudum C, Lindheim L, Ascani A, Trummer C, Horvath A, Münzker J, Obermayer-Pietsch B. Impact of Short-Term Isoflavone Intervention in Polycystic Ovary Syndrome (PCOS) Patients on Microbiota Composition and Metagenomics. Nutrients 2020;12:E1622. [PMID: 32492805 DOI: 10.3390/nu12061622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Wyns C, Straseski J, Gruson D. Biomarkers in reproductive health. Clin Biochem 2018;62:1. [PMID: 30347184 DOI: 10.1016/j.clinbiochem.2018.10.010] [Reference Citation Analysis]
3 Salva-Pastor N, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. J Steroid Biochem Mol Biol 2019;194:105445. [PMID: 31381969 DOI: 10.1016/j.jsbmb.2019.105445] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
4 Gharaei R, Mahdavinezhad F, Samadian E, Asadi J, Ashrafnezhad Z, Kashani L, Amidi F. Antioxidant supplementations ameliorate PCOS complications: a review of RCTs and insights into the underlying mechanisms. J Assist Reprod Genet 2021;38:2817-31. [PMID: 34689247 DOI: 10.1007/s10815-021-02342-7] [Reference Citation Analysis]
5 Zhao Y, Xu Y, Wang X, Xu L, Chen J, Gao C, Wu C, Pan D, Zhang Q, Zhou J, Chen R, Wang Z, Zhao H, You L, Cao Y, Li Z, Shi Y. Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study. J Clin Endocrinol Metab 2020;105:dgaa125. [PMID: 32163573 DOI: 10.1210/clinem/dgaa125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
6 Salva-Pastor N, López-Sánchez GN, Chávez-Tapia NC, Audifred-Salomón JR, Niebla-Cárdenas D, Topete-Estrada R, Pereznuñez-Zamora H, Vidaltamayo-Ramírez R, Báez-Arellano ME, Uribe M, Nuño-Lámbarri N. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population. Ann Hepatol 2020;19:251-7. [PMID: 32111488 DOI: 10.1016/j.aohep.2020.01.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Johansson HKL, Damdimopoulou P, van Duursen MBM, Boberg J, Franssen D, de Cock M, Jääger K, Wagner M, Velthut-Meikas A, Xie Y, Connolly L, Lelandais P, Mazaud-Guittot S, Salumets A, Draskau MK, Filis P, Fowler PA, Christiansen S, Parent AS, Svingen T. Putative adverse outcome pathways for female reproductive disorders to improve testing and regulation of chemicals. Arch Toxicol 2020;94:3359-79. [PMID: 32638039 DOI: 10.1007/s00204-020-02834-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
8 Park YJ, Shin H, Jeon S, Cho I, Park HJ. Development and Effects of College-Based Lifestyle Modification Program for Menstrual Health of Young Adult Women with Irregular Menses: A Randomized Controlled Trial. Int J Environ Res Public Health 2020;18:E233. [PMID: 33396852 DOI: 10.3390/ijerph18010233] [Reference Citation Analysis]